Gaithersburg, MD, United States of America

James C Butler


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2000-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of James C. Butler

Introduction

James C. Butler, an accomplished inventor based in Gaithersburg, MD, has made significant strides in the field of pharmaceuticals through his innovative research and inventions. With three patents to his name, Butler's work focuses primarily on oxypurine nucleosides and their applications in treating hematopoietic disorders and inflammatory diseases.

Latest Patents

Butler's latest patents include groundbreaking inventions that center on "Oxpurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis." This invention addresses the development of oxypurine nucleosides, their congeners, and acyl derivatives, as well as compositions comprising these compounds. The research presents methods for treating or preventing hematopoietic disorders, modifying hematopoiesis, and addressing inflammatory diseases and bacterial infections by administering these compounds to an animal.

Another notable patent by Butler is "Enhancing blood cell count with oxypurine nucleosides." Similar to his previous work, this invention also involves oxypurine nucleosides and highlights methods for enhancing blood cell count, thus contributing to the treatment and management of hematopoietic disorders and inflammatory diseases.

Career Highlights

Throughout his career, James C. Butler has worked with several notable companies, including Pro-neuron, Inc. and Wellstat Therapeutics Corporation. His contributions to these organizations have helped advance the research and application of innovative treatments through his patented inventions. Butler's research has opened new avenues for addressing hematological issues, significantly impacting the pharmaceutical landscape.

Collaborations

Collaboration is key to innovation, and Butler has worked alongside esteemed colleagues such as Reid W. Von Borstel and Michael K. Bamat. These partnerships have facilitated the exchange of ideas and expertise, further driving the development of impactful medical solutions.

Conclusion

James C. Butler is a notable inventor whose work in the field of oxypurine nucleosides has the potential to transform treatment options for hematopoietic disorders and inflammatory diseases. His contributions through patents and collaborative projects are paving the way for future advancements in this vital area of research. Butler's dedication to innovation continues to inspire those within the scientific and medical communities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…